Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1994-04

AUTHORS

Mariann Grossman, Steven E. Raper, Karen Kozarsky, Evan A. Stein, John F. Engelhardt, David Muller, Paul J. Lupien, James M. Wilson

ABSTRACT

An ex vivo approach to gene therapy for familial hypercholesterolaemia (FH) has been developed in which the recipient is transplanted with autologous hepatocytes that are genetically corrected with recombinant retroviruses carrying the LDL receptor. We describe the treatment of a 29 year old woman with homozygous FH by ex vivo gene therapy directed to liver. She tolerated the procedures well and in situ hybridization of liver tissue four months after therapy revealed evidence for engraftment of transgene expressing cells. The patient's LDL/HDL ratio declined from 10–13 before gene therapy to 5–8 following gene therapy, improvements which have remained stable for the duration of the treatment (18 months). This represents the first report of human gene therapy in which stable correction of a therapeutic endpoint has been achieved. More... »

PAGES

335-341

Journal

TITLE

Nature Genetics

ISSUE

4

VOLUME

6

Related Patents

  • Devices And Processes For Distribution Of Genetic Material To Mammalian Limb
  • Methods For Retroviral Mediated Gene Transfer Employing Molecules, Or Mixtures Thereof, Containing Retroviral Binding Domains And Target Cell Binding Domains
  • Methods And Compositions For Treatment Of A Beta Thalessemia
  • Preparation Of Non-Human Animals Having Chimeric Livers For Use Of Animal Models For Human Liver Toxins; Immunocompetent Animals Are Rendered Tolerant To Human Hepatocytes By Cell Or Lysate Administration During Embryonic Or Neonate Stage
  • Vector(S) Containing Genomic Dna, Cdna Or Rna Encoding A Replacement Gene Sequence Which Contains Altered Non-Coding Sequences That Can Not Be Recognized
  • Delivery Methods And Compositions For Nuclease-Mediated Genome Engineering
  • Nuclease-Mediated Regulation Of Gene Expression
  • Drug Delivery Of Polynucleotide To Primate Hepatocyte; High Level Of Gene Expression With Transient Increases In Liver Enzymes
  • Implantable System With Drug-Eluting Cells For On-Demand Local Drug Delivery
  • Transducing A Neuron With A Transgene From The Pseudotyped Retrovirus Virion; Gene Therapy For Neurodegenerative Diseases
  • Compositions And Methods For Ex Vivo Hepatic Nucleic Acid Delivery
  • Introducing Into Cells A Dna Molecule Coding For An Fc Receptor Which Is Then Expressed For Increased Phagocytic Activity; Combating Infection And/Or Modulating Immune Complex Disease
  • Method For Gene Transfer Into Target Cells With Retrovirus
  • A Pseudotyped Feline Immunodeficiency Virus Virion; Transfection; Expression Vectors Packaged In Packaging Cells To Generate High Titer Recombinant Virus Stocks; Gene Therapy
  • Genetic Suppression And Replacement
  • Delivery Methods And Compositions For Nuclease-Mediated Genome Engineering
  • Genetic Engineered Polynucleotides; Gene Therapy
  • Methods Of Stimulating Phagocytosis
  • Model System For Hepatitis C Virus Infection In Humans, Comprising Non-Human Animal Rendered Immunologically Tolerant To Human Hepatocytes And Subsequently Transplanted With Human Hepatocytes And Infected With Hepatitis C
  • Osteoactivin Protein And Nucleic Acids Encoding The Same, Compositions And Methods Of Stimulating Bone Differentiation
  • Method Of Treating Factor Ix Deficiency Using Nuclease-Mediated Targeted Integration
  • Preparing A Suppression Effector And Replacement Nucleic Acid That Have Modifications In One Or More Third Base (Wobble) Positions So That Replacement Nucleic Acids Still Code For The Wild Type Or Equivalent Amino Acids
  • Method For Gene Transfer Into Target Cells With Retrovirus; Improves Retroviral Vector Mediated Gene Transfer Efficiency Into Target Cells
  • Method Of Treating Mucopolysaccharidosis Type I Or Ii
  • Methods For Producing And Using In Vivo Pseudotyped Retroviruses Using Envelope Glycoproteins From Lymphocytic Choriomeningitis Virus (Lcmv)
  • A Pseudotyped Feline Immunodeficiency Virus Virion; Transfection; Expression Vectors Packaged In Packaging Cells To Generate High Titer Recombinant Virus Stocks; Gene Therapy
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/ng0494-335

    DOI

    http://dx.doi.org/10.1038/ng0494-335

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1016499584

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8054972


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biopsy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Coronary Artery Bypass", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Coronary Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Regulation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genes, Synthetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Vectors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperlipoproteinemia Type II", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Situ Hybridization, Fluorescence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipoproteins, HDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipoproteins, LDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Liver", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lovastatin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, LDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Safety", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Up-Regulation", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
                "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Grossman", 
            "givenName": "Mariann", 
            "id": "sg:person.0704474622.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704474622.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
                "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Raper", 
            "givenName": "Steven E.", 
            "id": "sg:person.01025305237.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025305237.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
                "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kozarsky", 
            "givenName": "Karen", 
            "id": "sg:person.01257637212.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257637212.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Research Laboratories, 45219, Cincinnati, Ohio, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Division of Lipid Metabolism and Preventive Atherosclerosis, The Christ Hospital Cardiovascular Research Center", 
                "Medical Research Laboratories, 45219, Cincinnati, Ohio, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stein", 
            "givenName": "Evan A.", 
            "id": "sg:person.01345624407.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345624407.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
                "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Engelhardt", 
            "givenName": "John F.", 
            "id": "sg:person.01220635046.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220635046.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
              "id": "http://www.grid.ac/institutes/grid.412590.b", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Muller", 
            "givenName": "David", 
            "id": "sg:person.01020723222.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020723222.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Lipid Research Center, Laval University Hospital Medical Research Center, G1V4G2, Qu\u00e9bec, Canada", 
              "id": "http://www.grid.ac/institutes/grid.449710.f", 
              "name": [
                "Lipid Research Center, Laval University Hospital Medical Research Center, G1V4G2, Qu\u00e9bec, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lupien", 
            "givenName": "Paul J.", 
            "id": "sg:person.01012770127.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012770127.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "name": [
                "Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA", 
                "Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilson", 
            "givenName": "James M.", 
            "id": "sg:person.016233130217.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016233130217.98"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf01233625", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034103858", 
              "https://doi.org/10.1007/bf01233625"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng0892-372", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013197479", 
              "https://doi.org/10.1038/ng0892-372"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng1192-240", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025456570", 
              "https://doi.org/10.1038/ng1192-240"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1994-04", 
        "datePublishedReg": "1994-04-01", 
        "description": "An ex vivo approach to gene therapy for familial hypercholesterolaemia (FH) has been developed in which the recipient is transplanted with autologous hepatocytes that are genetically corrected with recombinant retroviruses carrying the LDL receptor. We describe the treatment of a 29 year old woman with homozygous FH by ex vivo gene therapy directed to liver. She tolerated the procedures well and in situ hybridization of liver tissue four months after therapy revealed evidence for engraftment of transgene expressing cells. The patient's LDL/HDL ratio declined from 10\u201313 before gene therapy to 5\u20138 following gene therapy, improvements which have remained stable for the duration of the treatment (18 months). This represents the first report of human gene therapy in which stable correction of a therapeutic endpoint has been achieved.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/ng0494-335", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2423963", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2494212", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2436110", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1103138", 
            "issn": [
              "1061-4036", 
              "1546-1718"
            ], 
            "name": "Nature Genetics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "6"
          }
        ], 
        "keywords": [
          "gene therapy", 
          "ex vivo gene therapy", 
          "vivo gene therapy", 
          "human gene therapy", 
          "transgene expressing cells", 
          "LDL/HDL ratio", 
          "familial hypercholesterolaemia", 
          "ex vivo approach", 
          "Successful ex", 
          "recombinant retrovirus", 
          "autologous hepatocytes", 
          "year old woman", 
          "homozygous familial hypercholesterolaemia", 
          "HDL ratio", 
          "stable correction", 
          "therapeutic endpoints", 
          "older women", 
          "therapy", 
          "LDL receptor", 
          "four months", 
          "expressing cells", 
          "hypercholesterolaemia", 
          "vivo approaches", 
          "situ hybridization", 
          "treatment", 
          "first report", 
          "patients", 
          "engraftment", 
          "liver", 
          "endpoint", 
          "recipients", 
          "months", 
          "receptors", 
          "women", 
          "hepatocytes", 
          "retroviruses", 
          "duration", 
          "report", 
          "ex", 
          "cells", 
          "hybridization", 
          "evidence", 
          "improvement", 
          "ratio", 
          "procedure", 
          "approach", 
          "correction"
        ], 
        "name": "Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia", 
        "pagination": "335-341", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1016499584"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/ng0494-335"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8054972"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/ng0494-335", 
          "https://app.dimensions.ai/details/publication/pub.1016499584"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:20", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_231.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/ng0494-335"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ng0494-335'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ng0494-335'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ng0494-335'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ng0494-335'


     

    This table displays all metadata directly associated to this object as RDF triples.

    278 TRIPLES      21 PREDICATES      99 URIs      88 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/ng0494-335 schema:about N07409dd692ef42bab083c4b07784fec7
    2 N09b350b736b54a25ac91c2bfa4e6e1fe
    3 N1176e3e255fa4fc78e4eaa134b6c5d8a
    4 N1272418f793c4bb7907a4c011caae40b
    5 N12808660ed764844b2717ae91c775382
    6 N14caf208d86e4e13998ec7af8fc6e5ef
    7 N198ccde13125490f9401d37c712d4ec9
    8 N22cfcf0e014c46f7ba5df064fd70ee50
    9 N26881a9df9f2498198d5a2b8336fb82c
    10 N545b008d8e3c4929b5095bef6305e23c
    11 N55ea1e8a36114782abe8f731bc50561a
    12 N650d7871ca434f11b178afa5cb60b70c
    13 N6db16886103a4451a499ec3764aa5717
    14 N6dfcdd9e551341af8cbf33791a917fb9
    15 N8dcdc5c9532e4975bab8cf48d517a465
    16 N9c17ca8dee06460d96ac22a87f7e4f19
    17 Na52c501ffd624f07b1e0c3bbf652bc8b
    18 Na64a822b678f4c01887ab3feb1b14398
    19 Na87ff8eda6e440c2b2bb5651558f65fa
    20 Nb45bf5f93d24458fb4a84c2132095ee8
    21 Ncde6c0b812694ca1874dc6b3ff3ce9f9
    22 Ndfd48429110e47c29faa5d9919994c04
    23 Neb87b41e30ad4ac9b47b7bc670a80cb0
    24 anzsrc-for:06
    25 anzsrc-for:11
    26 schema:author Nd876fc0653ef48faa493dc6639cd5548
    27 schema:citation sg:pub.10.1007/bf01233625
    28 sg:pub.10.1038/ng0892-372
    29 sg:pub.10.1038/ng1192-240
    30 schema:datePublished 1994-04
    31 schema:datePublishedReg 1994-04-01
    32 schema:description An ex vivo approach to gene therapy for familial hypercholesterolaemia (FH) has been developed in which the recipient is transplanted with autologous hepatocytes that are genetically corrected with recombinant retroviruses carrying the LDL receptor. We describe the treatment of a 29 year old woman with homozygous FH by ex vivo gene therapy directed to liver. She tolerated the procedures well and in situ hybridization of liver tissue four months after therapy revealed evidence for engraftment of transgene expressing cells. The patient's LDL/HDL ratio declined from 10–13 before gene therapy to 5–8 following gene therapy, improvements which have remained stable for the duration of the treatment (18 months). This represents the first report of human gene therapy in which stable correction of a therapeutic endpoint has been achieved.
    33 schema:genre article
    34 schema:isAccessibleForFree false
    35 schema:isPartOf Na8deda1ac5334befa719089776e00c78
    36 Nad8816a3607c4733827d245a346644fb
    37 sg:journal.1103138
    38 schema:keywords HDL ratio
    39 LDL receptor
    40 LDL/HDL ratio
    41 Successful ex
    42 approach
    43 autologous hepatocytes
    44 cells
    45 correction
    46 duration
    47 endpoint
    48 engraftment
    49 evidence
    50 ex
    51 ex vivo approach
    52 ex vivo gene therapy
    53 expressing cells
    54 familial hypercholesterolaemia
    55 first report
    56 four months
    57 gene therapy
    58 hepatocytes
    59 homozygous familial hypercholesterolaemia
    60 human gene therapy
    61 hybridization
    62 hypercholesterolaemia
    63 improvement
    64 liver
    65 months
    66 older women
    67 patients
    68 procedure
    69 ratio
    70 receptors
    71 recipients
    72 recombinant retrovirus
    73 report
    74 retroviruses
    75 situ hybridization
    76 stable correction
    77 therapeutic endpoints
    78 therapy
    79 transgene expressing cells
    80 treatment
    81 vivo approaches
    82 vivo gene therapy
    83 women
    84 year old woman
    85 schema:name Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia
    86 schema:pagination 335-341
    87 schema:productId N7500bc1b8bee4e0f963726eb62e75202
    88 N91ef32ac8d824f21a77d5bd051b06c5d
    89 N99a9abf25a054f8ea29a9f5aec6abae4
    90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016499584
    91 https://doi.org/10.1038/ng0494-335
    92 schema:sdDatePublished 2022-12-01T06:20
    93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    94 schema:sdPublisher N7ff19993d63646b29fafb3c857f12feb
    95 schema:url https://doi.org/10.1038/ng0494-335
    96 sgo:license sg:explorer/license/
    97 sgo:sdDataset articles
    98 rdf:type schema:ScholarlyArticle
    99 N07409dd692ef42bab083c4b07784fec7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Safety
    101 rdf:type schema:DefinedTerm
    102 N09b350b736b54a25ac91c2bfa4e6e1fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Lipoproteins, LDL
    104 rdf:type schema:DefinedTerm
    105 N1176e3e255fa4fc78e4eaa134b6c5d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Follow-Up Studies
    107 rdf:type schema:DefinedTerm
    108 N1272418f793c4bb7907a4c011caae40b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Adult
    110 rdf:type schema:DefinedTerm
    111 N12808660ed764844b2717ae91c775382 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Gene Expression Regulation
    113 rdf:type schema:DefinedTerm
    114 N14caf208d86e4e13998ec7af8fc6e5ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Combined Modality Therapy
    116 rdf:type schema:DefinedTerm
    117 N198ccde13125490f9401d37c712d4ec9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Lovastatin
    119 rdf:type schema:DefinedTerm
    120 N22cfcf0e014c46f7ba5df064fd70ee50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Coronary Artery Bypass
    122 rdf:type schema:DefinedTerm
    123 N26881a9df9f2498198d5a2b8336fb82c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Up-Regulation
    125 rdf:type schema:DefinedTerm
    126 N482597d0101349d0880eee16cf4dead4 rdf:first sg:person.01020723222.01
    127 rdf:rest N75d26308da9149b8a405cdfc4d153eac
    128 N4bbcbffa85a748239c8705dd503ea3d6 rdf:first sg:person.01345624407.71
    129 rdf:rest N88780f3c2a9c4018bed492425e8c9818
    130 N545b008d8e3c4929b5095bef6305e23c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Liver
    132 rdf:type schema:DefinedTerm
    133 N55ea1e8a36114782abe8f731bc50561a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Cells, Cultured
    135 rdf:type schema:DefinedTerm
    136 N650d7871ca434f11b178afa5cb60b70c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Coronary Disease
    138 rdf:type schema:DefinedTerm
    139 N6db16886103a4451a499ec3764aa5717 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Humans
    141 rdf:type schema:DefinedTerm
    142 N6dfcdd9e551341af8cbf33791a917fb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name In Situ Hybridization, Fluorescence
    144 rdf:type schema:DefinedTerm
    145 N7500bc1b8bee4e0f963726eb62e75202 schema:name pubmed_id
    146 schema:value 8054972
    147 rdf:type schema:PropertyValue
    148 N75d26308da9149b8a405cdfc4d153eac rdf:first sg:person.01012770127.91
    149 rdf:rest Nfb03a2e4e2b34d438c69fb5780d78c28
    150 N7ff19993d63646b29fafb3c857f12feb schema:name Springer Nature - SN SciGraph project
    151 rdf:type schema:Organization
    152 N88780f3c2a9c4018bed492425e8c9818 rdf:first sg:person.01220635046.52
    153 rdf:rest N482597d0101349d0880eee16cf4dead4
    154 N8d73013f3f0f4023b3c1b3ef765c98fb rdf:first sg:person.01257637212.02
    155 rdf:rest N4bbcbffa85a748239c8705dd503ea3d6
    156 N8dcdc5c9532e4975bab8cf48d517a465 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Receptors, LDL
    158 rdf:type schema:DefinedTerm
    159 N91ef32ac8d824f21a77d5bd051b06c5d schema:name doi
    160 schema:value 10.1038/ng0494-335
    161 rdf:type schema:PropertyValue
    162 N99a9abf25a054f8ea29a9f5aec6abae4 schema:name dimensions_id
    163 schema:value pub.1016499584
    164 rdf:type schema:PropertyValue
    165 N9c17ca8dee06460d96ac22a87f7e4f19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Genetic Vectors
    167 rdf:type schema:DefinedTerm
    168 Na52c501ffd624f07b1e0c3bbf652bc8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Recombinant Proteins
    170 rdf:type schema:DefinedTerm
    171 Na64a822b678f4c01887ab3feb1b14398 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Genetic Therapy
    173 rdf:type schema:DefinedTerm
    174 Na87ff8eda6e440c2b2bb5651558f65fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Genes, Synthetic
    176 rdf:type schema:DefinedTerm
    177 Na8deda1ac5334befa719089776e00c78 schema:volumeNumber 6
    178 rdf:type schema:PublicationVolume
    179 Nad8816a3607c4733827d245a346644fb schema:issueNumber 4
    180 rdf:type schema:PublicationIssue
    181 Nb45bf5f93d24458fb4a84c2132095ee8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Lipoproteins, HDL
    183 rdf:type schema:DefinedTerm
    184 Nc647015652a241a7bf30b2246db6393f rdf:first sg:person.01025305237.98
    185 rdf:rest N8d73013f3f0f4023b3c1b3ef765c98fb
    186 Ncde6c0b812694ca1874dc6b3ff3ce9f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Hyperlipoproteinemia Type II
    188 rdf:type schema:DefinedTerm
    189 Nd876fc0653ef48faa493dc6639cd5548 rdf:first sg:person.0704474622.92
    190 rdf:rest Nc647015652a241a7bf30b2246db6393f
    191 Ndfd48429110e47c29faa5d9919994c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Biopsy
    193 rdf:type schema:DefinedTerm
    194 Neb87b41e30ad4ac9b47b7bc670a80cb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Female
    196 rdf:type schema:DefinedTerm
    197 Nfb03a2e4e2b34d438c69fb5780d78c28 rdf:first sg:person.016233130217.98
    198 rdf:rest rdf:nil
    199 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    200 schema:name Biological Sciences
    201 rdf:type schema:DefinedTerm
    202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    203 schema:name Medical and Health Sciences
    204 rdf:type schema:DefinedTerm
    205 sg:grant.2423963 http://pending.schema.org/fundedItem sg:pub.10.1038/ng0494-335
    206 rdf:type schema:MonetaryGrant
    207 sg:grant.2436110 http://pending.schema.org/fundedItem sg:pub.10.1038/ng0494-335
    208 rdf:type schema:MonetaryGrant
    209 sg:grant.2494212 http://pending.schema.org/fundedItem sg:pub.10.1038/ng0494-335
    210 rdf:type schema:MonetaryGrant
    211 sg:journal.1103138 schema:issn 1061-4036
    212 1546-1718
    213 schema:name Nature Genetics
    214 schema:publisher Springer Nature
    215 rdf:type schema:Periodical
    216 sg:person.01012770127.91 schema:affiliation grid-institutes:grid.449710.f
    217 schema:familyName Lupien
    218 schema:givenName Paul J.
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012770127.91
    220 rdf:type schema:Person
    221 sg:person.01020723222.01 schema:affiliation grid-institutes:grid.412590.b
    222 schema:familyName Muller
    223 schema:givenName David
    224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020723222.01
    225 rdf:type schema:Person
    226 sg:person.01025305237.98 schema:affiliation grid-institutes:grid.25879.31
    227 schema:familyName Raper
    228 schema:givenName Steven E.
    229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025305237.98
    230 rdf:type schema:Person
    231 sg:person.01220635046.52 schema:affiliation grid-institutes:grid.25879.31
    232 schema:familyName Engelhardt
    233 schema:givenName John F.
    234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220635046.52
    235 rdf:type schema:Person
    236 sg:person.01257637212.02 schema:affiliation grid-institutes:grid.25879.31
    237 schema:familyName Kozarsky
    238 schema:givenName Karen
    239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257637212.02
    240 rdf:type schema:Person
    241 sg:person.01345624407.71 schema:affiliation grid-institutes:None
    242 schema:familyName Stein
    243 schema:givenName Evan A.
    244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345624407.71
    245 rdf:type schema:Person
    246 sg:person.016233130217.98 schema:affiliation grid-institutes:grid.25879.31
    247 schema:familyName Wilson
    248 schema:givenName James M.
    249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016233130217.98
    250 rdf:type schema:Person
    251 sg:person.0704474622.92 schema:affiliation grid-institutes:grid.25879.31
    252 schema:familyName Grossman
    253 schema:givenName Mariann
    254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704474622.92
    255 rdf:type schema:Person
    256 sg:pub.10.1007/bf01233625 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034103858
    257 https://doi.org/10.1007/bf01233625
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1038/ng0892-372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013197479
    260 https://doi.org/10.1038/ng0892-372
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1038/ng1192-240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025456570
    263 https://doi.org/10.1038/ng1192-240
    264 rdf:type schema:CreativeWork
    265 grid-institutes:None schema:alternateName Medical Research Laboratories, 45219, Cincinnati, Ohio, USA
    266 schema:name Division of Lipid Metabolism and Preventive Atherosclerosis, The Christ Hospital Cardiovascular Research Center
    267 Medical Research Laboratories, 45219, Cincinnati, Ohio, USA
    268 rdf:type schema:Organization
    269 grid-institutes:grid.25879.31 schema:alternateName Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA
    270 schema:name Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA
    271 Institute for Human Gene Therapy, University of Pennsylvania, Wistar Institute, Room 204, 3601 Spruce Street, 19104-4268, Philadelphia, Pennsylvania, USA
    272 rdf:type schema:Organization
    273 grid-institutes:grid.412590.b schema:alternateName Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA
    274 schema:name Departments of Internal Medicine, Surgery, and Biological Chemistry, The University of Michigan Medical Center, 48109-0366, Ann Arbor, Michigan, USA
    275 rdf:type schema:Organization
    276 grid-institutes:grid.449710.f schema:alternateName Lipid Research Center, Laval University Hospital Medical Research Center, G1V4G2, Québec, Canada
    277 schema:name Lipid Research Center, Laval University Hospital Medical Research Center, G1V4G2, Québec, Canada
    278 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...